More answers like this
GPT-5Sep 10, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Leans yes
Short answer: We shouldn’t pause all AI, but we should be ready to pause scaling and deployment of the most capable (“frontier”) systems unless clear safety and governance conditions are met, and we should impose targeted restrictions on high‑risk uses.
Why not a blanket pause
•Costs: Slows medical, scientific, accessibility, and productivity gains; entrenches incumbents; pushes work to less regulated jurisdictions.
•Feasibility: Hard to coordinate globally; risks “shadow” development.
Why targeted pauses/restrictions make sense
•Risk is uneven: Most AI is low risk; a small subset (bio/cyber offense, high‑autonomy agents, powerful model weights released openly) can enable outsized harm.
•Precedent: Other tech domains use moratoria or staged approvals (clinical trials, nuclear testing, gene‑editing summits) until safeguards mature.
When to pause frontier scaling or deployments
•The model (or a fine‑tune/tool‑augmented version) can:
1)Materially enable novices to design/execute biological, chemical, or radiological threats.
2)Conduct or substantially automate serious cyber‑intrusions.
3)Deceive, manipulate, or autonomously pursue long‑horizon goals while evading oversight.
4)Significantly amplify disinformation or personalized persuasion at scale.
5)Resist control, exfiltrate itself, or replicate.
•And when mitigations (guardrails, monitoring, access controls) don’t robustly reduce these risks.
•Pauses should be conditional, temporary, and tied to clear safety criteria.
What restrictions and governance are warranted now
•Safety evaluations and audits: Mandatory pre‑deployment testing against standardized, independent red‑team and eval suites; third‑party audits for high‑risk models.
•Licensing for high‑compute training: Register and license training runs above a compute threshold; know‑your‑customer on cloud compute; secure development and model‑weight protection.
•Responsible release: Prefer API access over open weights for models with dangerous dual‑use capability; staged rollouts; rate‑limits and safety filters; provenance/watermarking of generated media.
•High‑risk use controls: Prohibit or tightly license uses in bio design, offensive cyber, autonomous operation of critical infrastructure, targeted political persuasion, and certain law‑enforcement contexts.
•Post‑deployment monitoring: Incident reporting (like aviation), abuse tracking, recall powers for unsafe models, and rapid patching expectations.
•Liability and duty of care: Clear accountability for developers and deployers; product safety standards; redress mechanisms for harms.
•Content authenticity: Support C2PA-style provenance, watermarks where feasible, and investment in robust detection ecosystems.
•International coordination: Align risk tiers and evals, share best practices, coordinate export controls on the most capable chips while keeping widely beneficial AI accessible.
•Research prioritization: Fund interpretability, scalable oversight, robust evaluation of dangerous capabilities, security of AI systems, and socio‑technical mitigations.
•Workforce and societal cushions: Training, transition support, and privacy/anti‑discrimination protections to manage near‑term impacts.
Criteria to lift a pause on frontier scaling
•The developer demonstrates, via independent evaluation and red‑team results, that the system does not cross dangerous‑capability thresholds—or that layered mitigations reliably contain them.
•Strong organizational security, incident response, and post‑deployment monitoring are in place.
•A regulator (or accredited auditor) certifies compliance with safety and governance standards.
Bottom line: Don’t stop AI across the board. Do impose proportionate restrictions and be willing to pause the riskiest frontier development until we have verified safety, enforceable governance, and credible containment of dangerous capabilities. This balances innovation with prudence.